June 24, 2019

Amring Pharmaceuticals Inc. (Amring), a generic pharmaceutical and ophthalmic medical device company, announced today that it has launched two valued drugs into its generic portfolio and to the U.S. Market: Succinylcholine Chloride Injection, a generic of Quelicin® , launched in April 2019, is used as an adjunct to general anesthesia to facilitate tracheal intubation, and it also provides skeletal muscle relaxation during surgery, and Mesalamine Suppositories, 1000 mg, a generic version of Canasa® Suppositories, an aminosalicylate indicated for the treatment of active ulcerative proctitis. Both drugs are distributed to retail, hospital, and/or institutional channels allowing Amring to continue adding value to its customers and patients across the U.S.
Read more

Amring
Products Partner Company LinkedIn
More news & events